World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

Clinical trial NCT06267326 · COMPLETED

Trial details

NCT number: NCT06267326
Sponsor: Nasser Institute For Research and Treatment
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mucormycosis; Rhinocerebral (Etiology)COVID-19

Start date: 2021-05-23
Primary completion: 2022-06-12
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.